Physician profile
Joy E Tu
NPI 1801520887
$3,139.56
in general payments reported to CMS, 2019-2025
20 companies · $1,285 in 2025
The $1,285 reported for 2025 was more than what 87% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $354 · 2023: $587 · 2024: $913 · 2025: $1,285.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,786.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,785.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $677.95 | 2023-2025 | Farxiga, Lokelma |
| Otsuka America Pharmaceutical, INC. | $402.14 | 2022-2025 | Jynarque, Voyxact |
| Bayer Healthcare Pharmaceuticals INC. | $289.79 | 2022-2025 | |
| Calliditas Therapeutics US INC. | $283.72 | 2023-2025 | Tarpeyo |
| Vifor Pharma, INC. | $251.57 | 2022-2025 | Veltassa, Korsuva |
| Amgen INC. | $186.06 | 2023-2025 | Tavneos, Krystexxa |
| Fresenius USA Marketing, INC. | $185.69 | 2022-2024 | Velphoro, Korsuva |
| Travere Therapeutics, INC. | $129.35 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $116.55 | 2023-2025 | Jardiance |
| Outset Medical INC | $109.54 | 2022 | |
| Ardelyx, INC. | $91.04 | 2024-2025 | Ibsrela |
| Daiichi Sankyo INC. | $88.57 | 2022-2025 | Injectafer |
| Mallinckrodt Hospital Products INC. | $70.19 | 2025 | Terlivaz, Acthar |
| Lilly USA, LLC | $65.40 | 2024-2025 | Jardiance |
| Glaxosmithkline, LLC. | $62.33 | 2023-2024 | Benlysta |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $55.53 | 2022 | |
| Scpharmaceuticals INC. | $21.09 | 2025 | |
| Aurinia Pharma U.S., INC. | $18.40 | 2024 | Lupkynis |
| Apellis Pharmaceuticals, INC. | $17.83 | 2025 | |
| Ani Pharmaceuticals, INC. | $16.82 | 2025 | Purified Cortrophin Gel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joy Tu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.